May 2006
Volume 47, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2006
Heparanase–1 Unlocks the Lacritin Binding Site on Co–Receptor Syndecan–1 as a Prerequisite for Subconfluent Ductal Proliferation
Author Affiliations & Notes
  • P. Ma
    Department of Cell Biology, University of Virginia, Charlottesville, VA
  • S. Beck
    Department of Cell Biology, University of Virginia, Charlottesville, VA
  • R. Raab
    James Madison University, Harrisonburg, VA
  • R. McKown
    James Madison University, Harrisonburg, VA
  • G. Coffman
    James Madison University, Harrisonburg, VA
  • A. Rapraeger
    University of Wisconsin–Madison, Madison, WI
  • G.W. Laurie
    Department of Cell Biology, University of Virginia, Charlottesville, VA
  • Footnotes
    Commercial Relationships  P. Ma, None; S. Beck, None; R. Raab, None; R. McKown, None; G. Coffman, None; A. Rapraeger, None; G.W. Laurie, None.
  • Footnotes
    Support  NIH Grant EY13143
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 1953. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      P. Ma, S. Beck, R. Raab, R. McKown, G. Coffman, A. Rapraeger, G.W. Laurie; Heparanase–1 Unlocks the Lacritin Binding Site on Co–Receptor Syndecan–1 as a Prerequisite for Subconfluent Ductal Proliferation . Invest. Ophthalmol. Vis. Sci. 2006;47(13):1953.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Lacritin is a small glycoprotein secreted by human lacrimal acinar cells. Lacritin signals to mTOR and NFATC1 via rapid PKCα; dephosphorylation and PLD activation to potentially modulate differentiation, renewal and secretion of lacrimal and corneal epithelia that it preferentially targets. Recently we showed that lacritin's C–terminus bound the core protein of a form of syndecan–1 distinct from the form that binds FGF2. We report here that heparanase digestion of heparan sulfate chains is required to expose the lacritin binding site on syndecan–1 as a prerequisite for mitogenesis.

Methods: : Human heparanase–1 was transiently transfected into HSG cells. Lysates from HEK293T cells stably transfected with syndecan–1 were sequentially affinity precipitated with FGF–2–GST or lacritin–intein fusion proteins. Heparanase was detected with antibodies directed against human heparanase followed by HRP–conjugated secondary antibody and ECL substrate. In mitogenic heparanase depletion assays, lacritin was added with [3H]–thymidine 48 hours after 1nM siRNA transfection. To rescure heparanase–depleted cells, 1 µg of heparin–enriched heparanase was added together with lacritin and [3H]–thymidine.

Results: : By sequential affinity precipitation, it is apparent that cells make both deglycosylated and native syndecan–1 available with the latter most prevalent. Lacritin binds deglycosylated syndecan–1 and FGF–2 binds heparan–sulfate decorated syndecan–1. 3G10 failed to detect syndecan–1 pulled down by lacritin–intein, but did so after heparitinase treatment. RNAi knockdown of the endo–ß–D–glucuronidase heparanase–1 incapacitates lacritin–dependent mitogenesis without affecting their response to EGF, and can be rescued by addition of exogenous heparanase.

Conclusions: : Mitogenic heparanase–dependent core protein binding appropriates a widely expressed cell surface proteoglycan as a cell–restrictive co–receptor. This unique coreceptor binding mechanism involves lower pH–dependent heparanase cleavage of heparan sulfate to expose a protein binding site on syndecan–1. This mechanism may offer protection against the low pH 'danger signal', one of several sudden cell stressing 'danger signals' thought to initiate primary Sjögren's syndrome. Supported by EY13143. No commercial support.

Keywords: cornea: tears/tear film/dry eye • lacrimal gland 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×